Exenatide does not slow Parkinson’s disease progression compared to placebo
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
Tag: Parkinson’s
Dementia is associated with high rates of sleep-related breathing disorders
1. In this meta-analysis, it was found that the pooled prevalence of sleep-related breathing disorders (SRBDs) among dementia patients was ...
Wellness Check: Sleep
Prior COVID-19 infection may result in poorer sleep health 1. In this cross-sectional study, it was found that participants had ...
Deferiprone is associated with worsening Parkinson’s symptoms in patients naïve to dopaminergic drugs
1. Deferiprone was associated with an increase in MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores compared to placebo, indicating worsening ...
#VisualAbstract: Prasinezumab therapy does not affect Parkinson’s Disease progression
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
Cinpanemab therapy does not prevent Parkinson’s disease progression
1. Cinpanemab did not show clinical efficacy in preventing early Parkinson’s disease (PD) progression compared to placebo. 2. There was ...
Prasinezumab therapy does not affect Parkinson’s Disease progression
1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinson’s disease progression. 2. Prasinezumab therapy was associated ...
Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease
1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were ...
Influenza is associated with an increased odds of Parkinson Disease diagnosis after 10 years
1. Inpatient or outpatient clinic diagnosed influenza infection was associated with an increased odds ratio of diagnosis with Parkinson Disease ...
Deep brain stimulation linked to declining brain function in Parkinson’s patients
1. Patients that received deep brain stimulation (DBS) surgery demonstrated significantly greater decline in neuropsychological function within 6 months when ...